Patents Assigned to Perseid Therapeutics, LLC
  • Patent number: 8496935
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: July 30, 2013
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E Karrer, Madan M. Paidhungat, Steven H Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Patent number: 8491899
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: July 23, 2013
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E Karrer, Madan M. Paidhungat, Steven H Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Patent number: 8445230
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: May 21, 2013
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E Karrer, Madan M. Paidhungat, Steven H Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Patent number: 8318176
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: November 27, 2012
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Patent number: 8283447
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: October 9, 2012
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Patent number: 8268587
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: September 18, 2012
    Assignee: Perseid Therapeutics LLC
    Inventors: Erik E Karrer, Madan M. Paidhungat, Steven H Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20120135912
    Abstract: The invention provides novel 2D-VCAM-1 variant polypeptides and conjugates thereof that bind human VLA4. The invention also provides related polynucleotides, compositions, vectors, host cells, and methods.
    Type: Application
    Filed: May 10, 2011
    Publication date: May 31, 2012
    Applicant: PERSEID THERAPEUTICS LLC
    Inventors: MADAN M. PAIDHUNGAT, AMULYA NANISETTI, THOMAS BOUQUIN, KIM VILBOUR ANDERSEN, STEVEN J. CHAPIN, CLAUS KREBBER, RONG A. FAN, DANIEL MALASHOCK, AMY BRIDEAU-ANDERSEN, ERIK KARRER, BRUCE DEVENS, STEVEN H. BASS
  • Patent number: 8071095
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: December 6, 2011
    Assignee: Perseid Therapeutics, LLC
    Inventors: Erik E Karrer, Madan M Paidhungat, Steven H Bass, Margaret Neighbors, Juha Punnonen, Steven J Chapin
  • Publication number: 20110182898
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: March 16, 2011
    Publication date: July 28, 2011
    Applicant: PERSEID THERAPEUTICS LLC
    Inventors: ERIK E. KARRER, MADAN M. PAIDHUNGAT, STEVEN H. BASS, MARGARET NEIGHBORS, JUHA PUNNONEN, STEVEN J. CHAPIN
  • Publication number: 20110177071
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: March 10, 2011
    Publication date: July 21, 2011
    Applicant: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20110166324
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: January 21, 2011
    Publication date: July 7, 2011
    Applicant: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20110159542
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 30, 2011
    Applicant: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20110130546
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 2, 2011
    Applicant: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20110129875
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 2, 2011
    Applicant: Perseid Therapeutics LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin
  • Publication number: 20100260759
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 14, 2010
    Applicant: PERSEID THERAPEUTICS LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin, Sridhar Viswanathan, Brent R. Larsen
  • Patent number: 7794718
    Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: September 14, 2010
    Assignee: Perseid Therapeutics, LLC
    Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin